Trial
NCT05927012
A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Keros Therapeutics, Inc.
Collaborators
—
Condition
Iron Deficiency Anemia
Intervention
KER-047
Why stopped
Despite several attempts to recruit eligible participants and major protocol amendments to increase the recruitment rate, recruitment challenges remained. Therefore, the Sponsor has made the decision to terminate the KER047-IR-202 Study globally.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-24